Notes in Primary CNS lymphoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.1 \| Epidemiology
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.2 \| Aetiology / RFs
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.3 \| Pathology
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.4 \| Clinical presentation
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 3.1 \| Management \| Overview
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 2.1 \| Workup
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 2.2 \| Appearance on MRI
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 2.3 \| DDx
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.5 \| Biologic behaviour
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.6 \| Prognostic factors
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 3.2 \| Management modalities
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 3.3 \| Chemotherapy
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 4 \| RT technique
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 1.7 \| Prognosis
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 4.1 \| Treatment toxicity
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 3.4 \| Evidnece
Published	02/18/2024	Haem \| Primary CNS lymphoma \| 3.5 \| Consolidation
Status	Last Update	Fields